vs
Side-by-side financial comparison of Hartford (The) (HIG) and Zoetis (ZTS). Click either name above to swap in a different company.
Hartford (The) is the larger business by last-quarter revenue ($4.1B vs $2.3B, roughly 1.8× Zoetis). Zoetis runs the higher net margin — 26.6% vs 13.2%, a 13.4% gap on every dollar of revenue. On growth, Hartford (The) posted the faster year-over-year revenue change (309.0% vs 2.9%). Over the past eight quarters, Zoetis's revenue compounded faster (-2.1% CAGR vs -20.8%).
The Hartford Insurance Group, Inc., known as The Hartford, is a U.S.-based insurance company. The Hartford is a Fortune 500 company headquartered in its namesake city of Hartford, Connecticut. It was ranked 162nd in Fortune 500 in 2024. The Hartford is a leader in property and casualty insurance, employee benefits and mutual funds. With more than 200 years of expertise, The Hartford is widely recognized for its service excellence, sustainability practices, trust and integrity. It sells produc...
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
HIG vs ZTS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $4.1B | $2.3B |
| Net Profit | $536.0M | $601.0M |
| Gross Margin | — | 71.7% |
| Operating Margin | — | — |
| Net Margin | 13.2% | 26.6% |
| Revenue YoY | 309.0% | 2.9% |
| Net Profit YoY | 12.0% | -0.2% |
| EPS (diluted) | — | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $4.1B | $2.3B | ||
| Q4 25 | $7.3B | $2.4B | ||
| Q3 25 | $7.2B | $2.4B | ||
| Q2 25 | $7.0B | $2.5B | ||
| Q1 25 | $6.8B | $2.2B | ||
| Q4 24 | $6.9B | $2.3B | ||
| Q3 24 | $6.8B | $2.4B | ||
| Q2 24 | $6.5B | $2.4B |
| Q1 26 | $536.0M | $601.0M | ||
| Q4 25 | — | $603.0M | ||
| Q3 25 | $1.1B | $721.0M | ||
| Q2 25 | $995.0M | $718.0M | ||
| Q1 25 | $630.0M | $631.0M | ||
| Q4 24 | — | $581.0M | ||
| Q3 24 | $767.0M | $682.0M | ||
| Q2 24 | $738.0M | $624.0M |
| Q1 26 | — | 71.7% | ||
| Q4 25 | — | 70.2% | ||
| Q3 25 | — | 71.5% | ||
| Q2 25 | — | 73.6% | ||
| Q1 25 | — | 72.0% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 71.7% |
| Q1 26 | — | — | ||
| Q4 25 | 19.3% | 31.9% | ||
| Q3 25 | 18.2% | 37.0% | ||
| Q2 25 | 17.8% | 36.7% | ||
| Q1 25 | 11.5% | 36.5% | ||
| Q4 24 | 15.6% | 31.6% | ||
| Q3 24 | 14.1% | 36.6% | ||
| Q2 24 | 14.1% | 33.0% |
| Q1 26 | 13.2% | 26.6% | ||
| Q4 25 | — | 25.3% | ||
| Q3 25 | 14.9% | 30.0% | ||
| Q2 25 | 14.2% | 29.2% | ||
| Q1 25 | 9.3% | 28.4% | ||
| Q4 24 | — | 25.1% | ||
| Q3 24 | 11.4% | 28.6% | ||
| Q2 24 | 11.4% | 26.4% |
| Q1 26 | — | $1.42 | ||
| Q4 25 | $3.96 | $1.37 | ||
| Q3 25 | $3.77 | $1.63 | ||
| Q2 25 | $3.44 | $1.61 | ||
| Q1 25 | $2.15 | $1.41 | ||
| Q4 24 | $2.88 | $1.29 | ||
| Q3 24 | $2.56 | $1.50 | ||
| Q2 24 | $2.44 | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $16.8M | — |
| Total Assets | $86.3M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.7M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | $4.4B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.4B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.4B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $4.4B | — |
| Q1 26 | $16.8M | — | ||
| Q4 25 | $19.0B | $3.3B | ||
| Q3 25 | $18.4B | $5.4B | ||
| Q2 25 | $17.5B | $5.0B | ||
| Q1 25 | $16.8B | $4.7B | ||
| Q4 24 | $16.4B | $4.8B | ||
| Q3 24 | $17.0B | $5.2B | ||
| Q2 24 | $15.7B | $5.0B |
| Q1 26 | $86.3M | — | ||
| Q4 25 | $86.0B | $15.5B | ||
| Q3 25 | $85.0B | $15.2B | ||
| Q2 25 | $83.6B | $14.5B | ||
| Q1 25 | $82.3B | $14.1B | ||
| Q4 24 | $80.9B | $14.2B | ||
| Q3 24 | $81.2B | $14.4B | ||
| Q2 24 | $79.0B | $14.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.23× | — | ||
| Q3 25 | 0.24× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.26× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | 0.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIG
| Earned premiums | $3.6B | 88% |
| Other | $486.0M | 12% |
| Fee income | $12.0M | 0% |
ZTS
| Companion Animal | $1.5B | 67% |
| Livestock | $720.0M | 32% |
| Contract Manufacturing & Human Health | $23.0M | 1% |
